mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0003 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
0.5 |
0.002 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |